Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Contractor Gets Route 92 Medical Catheters Class I Recall Due to Distal Tip Separation

  • Post author:PacConAdmin
  • Post published:May 13, 2024
  • Post category:Uncategorized

Route 92 Medical is recalling medical products containing its Tenzing 7 delivery catheters due to multiple instances of distal tip separation at the proximal marker band. Source: Drug Industry Daily

Continue ReadingContractor Gets Route 92 Medical Catheters Class I Recall Due to Distal Tip Separation

Megadyne Discontinues, Recalls Pediatric Patient Return Electrodes

  • Post author:PacConAdmin
  • Post published:May 13, 2024
  • Post category:Uncategorized

Reports of patient burn injuries have prompted Megadyne Medical Products to institute a global discontinuation and voluntary recall of its Mega Soft Pediatric Patient Return Electrodes. Source: Drug Industry Daily

Continue ReadingMegadyne Discontinues, Recalls Pediatric Patient Return Electrodes

Legislative Update — Week of May 13, 2024

  • Post author:PacConAdmin
  • Post published:May 13, 2024
  • Post category:Uncategorized

As the second session of the 118th Congress begins, FDAnews will track important pending legislation, that has been acted on since Oct. 1, 2023 to keep you updated on laws…

Continue ReadingLegislative Update — Week of May 13, 2024

Quick Notes: Device Clearances and Approvals — May 10, 2024

  • Post author:PacConAdmin
  • Post published:May 10, 2024
  • Post category:Uncategorized

This edition of Quick Notes reviews the FDA’s 510(k) clearance of Outset Medical’s TabloCart as well as perfusion imaging analysis by RapidAI and an OTC version of the Masimo Stork…

Continue ReadingQuick Notes: Device Clearances and Approvals — May 10, 2024

UK Regulator Tackles AIaMD With AI Airlock Launch

  • Post author:PacConAdmin
  • Post published:May 10, 2024
  • Post category:Uncategorized

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) continued its proactive approach to regulating standalone AI medical devices (AIaMD) with Thursday’s launch of its AI Airlock sandbox model, allowing…

Continue ReadingUK Regulator Tackles AIaMD With AI Airlock Launch

Medical Device Reporting Violations Merit Company an FDA Warning Letter

  • Post author:PacConAdmin
  • Post published:May 10, 2024
  • Post category:Uncategorized

The FDA’s recent Warning Letter to Augustine Temperature Management focused on a single — issue problems with medical device reporting (MDR) — citing the Bloomington, Minn.,-based company for multiple failures…

Continue ReadingMedical Device Reporting Violations Merit Company an FDA Warning Letter

Regulatory Update — Week of May 6, 2024

  • Post author:PacConAdmin
  • Post published:May 10, 2024
  • Post category:Uncategorized

This week, the FDA announced its final rule for laboratory developed tests. Draft guidances were published on enforcement policies for tests during a Section 564 declared emergency, IVD enforcement policy…

Continue ReadingRegulatory Update — Week of May 6, 2024

Health Care Monopoly and Collusion Task Force Formed by DOJ

  • Post author:PacConAdmin
  • Post published:May 10, 2024
  • Post category:Uncategorized

The Department of Justice (DOJ) has formed a new enforcement arm — the Task Force Health Care Monopolies and Collusion (HCMC) — to guide the department’s policy approach for healthcare,…

Continue ReadingHealth Care Monopoly and Collusion Task Force Formed by DOJ

Regulatory Plan Calls on FDA, USDA and EPA to Coordinate on Biotechnology Products

  • Post author:PacConAdmin
  • Post published:May 9, 2024
  • Post category:Uncategorized

The FDA has joined forces with the Environmental Protection Agency (EPA) and the Department of Agriculture (USDA) on a plan to regulate genetically modified organisms and biotechnology products for humans.…

Continue ReadingRegulatory Plan Calls on FDA, USDA and EPA to Coordinate on Biotechnology Products

Safety, Quality Concerns Cause FDA to Issue Alert on Getinge/Maquet Cardiac Devices

  • Post author:PacConAdmin
  • Post published:May 9, 2024
  • Post category:Uncategorized

Concerns about unexpected shutdown leading to possible injury and/or death has caused the FDA to issue an alert about several cardiac devices manufactured by Getinge/Datascope/Maquet. Source: Drug Industry Daily

Continue ReadingSafety, Quality Concerns Cause FDA to Issue Alert on Getinge/Maquet Cardiac Devices
  • Go to the previous page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 144
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company